Loading...
•
Dec 31, 2025
Prestige Consumer Q3 2026 Earnings Report
Prestige Consumer Healthcare Inc. reported its third quarter and nine months fiscal 2026 results.
Key Takeaways
Prestige Consumer Healthcare Inc. exceeded its third quarter revenue outlook and delivered solid profitability, reflecting the benefits of its diverse business model and strong financial profile. The company continued to make progress toward improving Clear Eyes® supply, increasing sales sequentially, and closed the acquisition of Pillar5 in December. Despite a challenging consumer backdrop, the company's superior free cash flow and low leverage allowed for opportunistic share repurchases.
Revenue of $283.4 million in Q3, ahead of outlook.
Diluted EPS of $0.97 in Q3 and Adjusted Diluted EPS of $1.14, versus prior year Q3 Diluted EPS of $1.22.
Approximately 0.8 million shares were repurchased opportunistically in Q3.
Successfully closed the acquisition of eye care supplier Pillar5 Pharma, Inc. in December, as expected.
Revenue by Segment
Forward Guidance
The company is narrowing its fiscal 2026 net sales outlook to approximately $1.1 billion, reflecting a continued challenging consumer environment, while maintaining its outlook for free cash flow of $245 million or higher.
Positive Outlook
- Continued focus on rebuilding supply chain capacity for Clear Eyes®.
- Expectation of supply improvements in coming quarters to support long-term demand.
- Maintaining outlook for strong and stable financial performance with free cash flow of $245 million or higher.
- Continued focus on brand-building to drive long-term organic growth.
- Disciplined capital allocation to generate superior shareholder value creation over time.
Challenges Ahead
- Narrowing fiscal 2026 net sales outlook to approximately $1.1 billion.
- Continued challenging consumer environment impacting net sales.
- Projected organic revenue growth decrease of approximately 3.0%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...